erythrosine has been researched along with pyrazolanthrone in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allshire, A; Anoopkumar-Dukie, S; Carey, JB; Conere, T | 1 |
Abid, MN; Ahmad, A; Khan, M; Kim, MO; Rehman, SU; Yoon, GH | 1 |
Armstead, WM; Cines, DB; Higazi, AA; Kiessling, JW; Riley, J | 1 |
3 other study(ies) available for erythrosine and pyrazolanthrone
Article | Year |
---|---|
Radical mediators and mitogen-activated protein kinase signaling in oxygen-dependent radiosensitivity of human tumor cell lines.
Topics: Acetylcysteine; Anthracenes; Antioxidants; Apoptosis; Ascorbic Acid; Butadienes; Cell Line, Tumor; Cell Proliferation; DNA Damage; Enzyme Inhibitors; Fluoresceins; HeLa Cells; Humans; Imidazoles; MAP Kinase Signaling System; Melatonin; Mitochondria; Nitriles; Nitrites; Oxazines; Oxygen; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Radiation Tolerance; Rhodamines; Spectrometry, Fluorescence; Xanthenes | 2005 |
Inhibition of c-Jun N-Terminal Kinase Protects Against Brain Damage and Improves Learning and Memory After Traumatic Brain Injury in Adult Mice.
Topics: Amyloid beta-Peptides; Animals; Anthracenes; Blood-Brain Barrier; Brain; Brain Edema; Brain Injuries, Traumatic; Cytokines; Disease Models, Animal; Enzyme Inhibitors; Fluoresceins; JNK Mitogen-Activated Protein Kinases; Learning Disabilities; Maze Learning; Mice; Mice, Inbred C57BL; Peptide Fragments; Psychomotor Performance | 2018 |
Novel plasminogen activator inhibitor-1-derived peptide protects against impairment of cerebrovasodilation after photothrombosis through inhibition of JNK MAPK.
Topics: Animals; Animals, Newborn; Anthracenes; Cerebrovascular Circulation; Disease Models, Animal; Erythrosine; Female; Fibrinolytic Agents; Imidazoles; Intracranial Thrombosis; JNK Mitogen-Activated Protein Kinases; Lasers, Solid-State; Male; p38 Mitogen-Activated Protein Kinases; Peptides; Protein Kinase Inhibitors; Pyridines; Recombinant Proteins; Swine; Time Factors; Tissue Plasminogen Activator; Vasoconstriction; Vasodilation | 2010 |